Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
0.882 | 0.040 | 9 | 85002156 | intron variant | G/A | snv | 0.74 |
|
Mental Disorders | 0.010 | 1.000 | 1 | 2013 | 2013 | |||||||
|
0.882 | 0.040 | 9 | 85002156 | intron variant | G/A | snv | 0.74 |
|
Mental Disorders | 0.010 | 1.000 | 1 | 2013 | 2013 | |||||||
|
1.000 | 0.040 | 9 | 84822934 | intron variant | A/G | snv | 0.40 |
|
Endocrine System Diseases | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||||
|
1.000 | 0.040 | 9 | 84822934 | intron variant | A/G | snv | 0.40 |
|
Nutritional and Metabolic Diseases; Endocrine System Diseases | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||||
|
1.000 | 0.040 | 9 | 84804874 | intron variant | C/G | snv | 0.55 |
|
Nutritional and Metabolic Diseases; Endocrine System Diseases | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||||
|
1.000 | 0.040 | 9 | 84804874 | intron variant | C/G | snv | 0.55 |
|
Endocrine System Diseases | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||||
|
0.882 | 0.080 | 9 | 84668501 | upstream gene variant | C/A;G;T | snv |
|
Mental Disorders | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||||||
|
0.882 | 0.080 | 9 | 84668501 | upstream gene variant | C/A;G;T | snv |
|
Nervous System Diseases; Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||||||
|
0.851 | 0.120 | 9 | 84667612 | upstream gene variant | C/T | snv | 0.50 |
|
Mental Disorders | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||||
|
1.000 | 0.040 | 9 | 84707625 | intron variant | T/C | snv | 0.50 |
|
Mental Disorders | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||||
|
0.925 | 0.080 | 9 | 84673278 | intron variant | G/A;T | snv |
|
Behavior and Behavior Mechanisms | 0.010 | 1.000 | 1 | 2016 | 2016 | ||||||||
|
0.925 | 0.080 | 9 | 84835851 | intron variant | G/A | snv | 0.39 |
|
Behavior and Behavior Mechanisms | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.925 | 0.040 | 9 | 84878840 | intron variant | C/T | snv | 0.40 |
|
Nervous System Diseases | 0.020 | 1.000 | 2 | 2017 | 2017 | |||||||
|
0.925 | 0.040 | 9 | 84878840 | intron variant | C/T | snv | 0.40 |
|
Nervous System Diseases | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.925 | 0.040 | 9 | 84878840 | intron variant | C/T | snv | 0.40 |
|
Mental Disorders | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.925 | 0.040 | 9 | 84878840 | intron variant | C/T | snv | 0.40 |
|
Mental Disorders | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.925 | 0.040 | 9 | 84878840 | intron variant | C/T | snv | 0.40 |
|
Mental Disorders | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||||
|
1.000 | 0.040 | 9 | 84673625 | intron variant | T/C | snv | 0.50 |
|
Mental Disorders | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.925 | 0.040 | 9 | 84678542 | intron variant | T/A;C | snv |
|
Mental Disorders | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||||||
|
0.851 | 0.120 | 9 | 84667612 | upstream gene variant | C/T | snv | 0.50 |
|
Pathological Conditions, Signs and Symptoms | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.851 | 0.120 | 9 | 84667612 | upstream gene variant | C/T | snv | 0.50 |
|
Nervous System Diseases; Mental Disorders; Behavior and Behavior Mechanisms | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.851 | 0.120 | 9 | 84667612 | upstream gene variant | C/T | snv | 0.50 |
|
Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Mental Disorders | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.851 | 0.120 | 9 | 84667612 | upstream gene variant | C/T | snv | 0.50 |
|
Nervous System Diseases; Mental Disorders | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||||
|
1.000 | 0.080 | 9 | 84713003 | intron variant | A/G | snv | 0.50 |
|
Chemically-Induced Disorders; Mental Disorders | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||||
|
9 | 84919243 | intron variant | G/A | snv | 0.81 |
|
Pathological Conditions, Signs and Symptoms; Nervous System Diseases | 0.010 | 1.000 | 1 | 2017 | 2017 |